2025年3月12日 · Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is used to treat HIV infection. Includes Genvoya side effects, interactions and indications.

2023年6月14日 · GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) is a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide for oral administration. Elvitegravir is an HIV -1 integrase strand transfer inhibitor.

GENVOYA® is a combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. See Patient Information with important warnings.

Find healthcare professional information about GENVOYA® (elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide). See full Prescribing Info, & BOXED WARNING.

What is Genvoya used for? Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is used to treat human immunodeficiency virus (HIV). Genvoya may also be used for other...

GENVOYA is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to …

2022年9月23日 · Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is an oral tablet prescribed to treat HIV. Learn about its side effects, uses, cost, and more.

Genvoya is a fixed-dose, four-drug combination treatment for HIV-1 disease. Genvoya contains: Elvitegravir, an HIV-1 integrase strand transfer inhibitor (INSTI). INSTIs block the action of the enzyme integrase that facilitates insertion of the HIV virus into the cell.

2024年11月13日 · What is Genvoya? Genvoya is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children who weigh at least 55 lb (25 kg) and meet certain requirements, as …

Genvoya is an antiviral medicine used to treat individuals infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).